ONCIN — Oncoinvent ASA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual balance sheet for Oncoinvent ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	R2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	437	151	156	134	178
Net Total Accounts Receivable
Net Total Receivables	11.7	14.1	10.1	5.83	7.79
Prepaid Expenses
Total Other Current Assets
Total Current Assets	449	167	174	142	187
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.19	0.043	0.431	26.7	15.6
Other Long Term Assets
Total Assets	450	167	174	171	205
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	64.9	77.9	46.9	57.9	58
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	65.8	78.2	46.9	62.7	58.6
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	384	88.5	127	108	146
Total Liabilities & Shareholders' Equity	450	167	174	171	205
Total Common Shares Outstanding